Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Haferkamp

Showing results (111-120 of 298) with videos related to

Pageof 30
Sort By:
Urologia Internationalis|October 18, 2007
Characterization of primary renal carcinoma culturesElisabeth Sievers, Patrick Dreimuller, Axel Haferkamp, et al.
Life Sciences|January 4, 2011
Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
Qualitative Twitter analysis of participants, tweet strategies, and tweet content at a major urologic conferenceHendrik Borgmann, Jan-Henning Woelm, Axel Merseburger, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2025
Development of an artificial intelligence-generated, explainable treatment recommendation system for urothelial carcinoma and renal cell carcinoma to support multidisciplinary cancer conferencesGregor Duwe, Dominique Mercier, Verena Kauth, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 20, 2018
Immune check point inhibitors for metastatic urothelial carcinoma: current evidence-based approach for urology daily practiceNikita D Nabar, Maximilian P Brandt, Christian Thomas, et al.
Urologia Internationalis|March 8, 2021
Phase 2 of the Coronavirus Pandemic in Urology: Ramping Up Surgical Caseload and Resident Training while COVID-19 Infections DecreaseHendrik Borgmann, Katharina Boehm, Maximilian Peter Brandt, et al.
World Journal of Urology|January 4, 2011
PSA density lower cutoff value as a tool to exclude pathologic upstaging in initially diagnosed unilateral prostate cancer: impact on hemiablative focal therapyThomas Hofner, Jesco Pfitzenmaier, Adel Alrabadi, et al.
BJU International|April 22, 2008
Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mLJesco Pfitzenmaier, Christian Gilfrich, Maria Pritsch, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 5, 2017
Testicular Cancer on the Web-an Appropriate Source of Patient Information in Concordance with the European Association of Urology Guidelines?Pia Paffenholz, Johannes Salem, Hendrik Borgmann, et al.
Cancers|October 14, 2022
Concomitant Use of Sulforaphane Enhances Antitumor Efficacy of Sunitinib in Renal Cell Carcinoma In VitroIgor Tsaur, Anita Thomas, Emine Taskiran, et al.
Pageof 30

Showing results (111-120 of 298) with videos related to

Sort By:
Pageof 30
Urologia Internationalis|October 18, 2007
Characterization of primary renal carcinoma culturesElisabeth Sievers, Patrick Dreimuller, Axel Haferkamp, et al.
Life Sciences|January 4, 2011
Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
Qualitative Twitter analysis of participants, tweet strategies, and tweet content at a major urologic conferenceHendrik Borgmann, Jan-Henning Woelm, Axel Merseburger, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2025
Development of an artificial intelligence-generated, explainable treatment recommendation system for urothelial carcinoma and renal cell carcinoma to support multidisciplinary cancer conferencesGregor Duwe, Dominique Mercier, Verena Kauth, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 20, 2018
Immune check point inhibitors for metastatic urothelial carcinoma: current evidence-based approach for urology daily practiceNikita D Nabar, Maximilian P Brandt, Christian Thomas, et al.
Urologia Internationalis|March 8, 2021
Phase 2 of the Coronavirus Pandemic in Urology: Ramping Up Surgical Caseload and Resident Training while COVID-19 Infections DecreaseHendrik Borgmann, Katharina Boehm, Maximilian Peter Brandt, et al.
World Journal of Urology|January 4, 2011
PSA density lower cutoff value as a tool to exclude pathologic upstaging in initially diagnosed unilateral prostate cancer: impact on hemiablative focal therapyThomas Hofner, Jesco Pfitzenmaier, Adel Alrabadi, et al.
BJU International|April 22, 2008
Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mLJesco Pfitzenmaier, Christian Gilfrich, Maria Pritsch, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 5, 2017
Testicular Cancer on the Web-an Appropriate Source of Patient Information in Concordance with the European Association of Urology Guidelines?Pia Paffenholz, Johannes Salem, Hendrik Borgmann, et al.
Cancers|October 14, 2022
Concomitant Use of Sulforaphane Enhances Antitumor Efficacy of Sunitinib in Renal Cell Carcinoma In VitroIgor Tsaur, Anita Thomas, Emine Taskiran, et al.
Pageof 30